AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 OCT 3 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive, Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) Tablets for the prevention of pregnancy. Ortho Tri-Cyclen Lo will be available by prescription in the fall.
Like other oral contraceptives, Ortho Tri-Cyclen Lo, is highly effective when taken correctly. It contains a combination of hormones - estrogen and the progestin norgestimate.
Ortho Tri-Cyclen Lo was developed by Ortho-McNeil Pharmaceutical, Inc.
"Ortho Tri-Cyclen Lo is an important new option in birth control, and one that I believe women will be excited about," said Ronald T. Burkman, MD, Bay State Medical Center, department of obstetrics and gynecology, Springfield, Massachusetts "The distinctive combination of a lower dose of estrogen with the trusted progestin, norgestimate, provides women a new option in birth control that is highly effective and has a ...
Source: HighBeam Research, New low-dose Ortho Tri-Cyclen approved by FDA.(Brief Article)